MariMed Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 38.9 million compared to USD 35.83 million a year ago. Net loss was USD 10.17 million compared to net income of USD 4.75 million a year ago.

Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago.